VALUE DRUG COMPANY v. ONLY ONE HUB, INC.

CourtDistrict Court, W.D. Pennsylvania
DecidedJuly 3, 2024
Docket3:23-cv-00263
StatusUnknown

This text of VALUE DRUG COMPANY v. ONLY ONE HUB, INC. (VALUE DRUG COMPANY v. ONLY ONE HUB, INC.) is published on Counsel Stack Legal Research, covering District Court, W.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
VALUE DRUG COMPANY v. ONLY ONE HUB, INC., (W.D. Pa. 2024).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE WESTERN DISTRICT OF PENNSYLVANIA

VALUE DRUG COMPANY, ) ) Plaintiff, ) v. ) Civil No. 3:23-cv-00263 ) Judge Stephanie Haines ONLY ONE HUB, INK. A/K/A ONLY ) ONE HUB D/B/A/ PRIMUS ) HEALTHCARE AND RICHARD ) HERSPERGER, ) ) Defendants. ) OPINION Value Drug Company (“VDC”) filed a Complaint in civil action (ECF No. 1) in Blair County, Pennsylvania against defendants Only One Hub, Inc. also known as Only One Hub doing business as Primus Healthcare (“OOH”), and against Richard Hersperger (“Hersperger”) (collectively “Defendants”). Hersperger is the owner and Chief Executive Officer of OOH as well as a shareholder of OOH. On October 26, 2023, OOH filed a Notice of Removal with the United States District Court for the Western District of Pennsylvania (ECF No. 1; ECF No. 1-2, pp. 95- 206 (Exhibit A — Complaint and civil documents)) and the case was placed with this Federal Court. After deficient attempts to file Motions to Dismiss by Defendants (ECF Nos. 8,13,16,17), OOH filed a Second Motion to Dismiss (ECF No. 29) and Brief (ECF No. 30) and Hersperger did the same (ECF Nos. 31, 32). Value Drug responded to OOH (ECF No. 38) and Hersperger (ECF No. 37). In the interim, the Court granted a Motion for Preliminary Injunction in the form of a limited receiver (ECF Nos. 11, 24, 25), and assigned the limited receiver on February 13, 2024 (ECF No. 40). The Court will now address the Motions to Dismiss filed by defendant OOH and

defendant Hersperger in turn. When Defendants’ arguments are duplicative, the Court will address the issues applying the analysis to both Defendants. 1. FACTS! VDC is a cooperative of independent pharmacies. ECF No. 12, p. 2. It entered a collaborative with OOH that was intended to be mutually beneficial to OOH, VDC, and the member pharmacies of VDC. The First Project Agreement commemorating the collaborative was in June 2021, and it provided that all physicians involved in the collaborative would be clients of Triple B Billing & Consulting, Inc. (“BBB”). ECF No. 1-2, p. 16, {4 29-31. In general, BBB would conduct all accounting matters and would be overseen by OOH. VDC complains of various problems that occurred under the First Project Agreement yet entered into the Second Project Agreement on October 28, 2021. ECF No. 1-2, pp. 11-12, 9] 58-62. Under the Second Project Agreement, all physicians were clients of Medical Service Associates (“MSA”) or OOH, instead of BBB. All other terms of the First Project Agreement remained the same.” The Second Project Agreement states the term as “One Year from the date of Execution “Execution Date” and continues in full force and effect for a period of one year. Agreement will renew for another year provided all parties agree no less than 30 days prior to the anniversary date.” > ECF No. 1-2, p. 73. According to the Agreements, VDC’s member pharmacies would conduct interviews with patients, provide instructions to patients for test sampling procedures, collect COVID-19 test samples, and submit the test samples to Genotox Laboratories utilizing packing provided by OOH. ECF No. 1-2, p. 15, § 22. The pharmacies (and in turn VDC and OOH) would be paid through an

! The facts derive from VDC’s Complaint (ECF No. 1-2). 2 See Complaint for complete description of the responsibilities of the parties to the agreement and the representative shares of the profits (ECF No. 1-2, p, 21-22, J] 64-70). See also Second Project Agreement (ECF No. 1-2, Exhibit C, argues that the Second Project Agreement was renewed by participation and did not require a signed writing. This Court need not determine whether the Second Project Agreement is expired. Termination of a contract does not excuse the parties from past performance that arose under a valid contract. ECF No. 19, p. 5.

arrangement in which a physician or other qualified nonphysician practitioner would bill for the services provided by pharmacies, then provide the pharmacies with the agreed-upon reimbursement. Jd. §20. VDC and OOH were to provide relevant software, and OOH was to provide the COVID-19 tests to VDC, which VDC then provided to the pharmacies. Jd. { 23. OOH managed and oversaw the project, as well as retained, managed, and oversaw the third-party billing company that would submit and collect payments on project claims. /d. § 21. VDC states that neither it nor its member pharmacies were responsible for, or had control over, claims submission, processing, or payment. ECF No. 12, p. 3. VDC asserts that Defendants engaged in misconduct, mismanagement, and fraud in the following ways: a) failing to properly submit Project claims; b) failing to obtain reimbursements for Covid-19 tests performed as part of the Project; c) using improper billing codes to submit claims for the Project; d) failing to properly segregate and place into escrow Project payments received; e) failing to properly distribute Project funds; f) failing to provide adequate reports, updates and information to Value Drug and other Project participants; g) making numerous misrepresentations and material omissions to both Value Drug and Value Drug’s member pharmacies related to the Project; and h) failing to pay both Value Drug and Value Drug’s member pharmacies for Covid-19 tests performed as part of the Project. ECF No. 12, pp. 3-4. Il. STANDARD A motion to dismiss pursuant to Federal Rule of Civil Procedure 12(b)(6) tests the legal sufficiency of the complaint. See Kost v. Kozakiewicz, | F.3d 176, 183 (3d Cir. 1993). In deciding a motion to dismiss, the Court is not opining on whether the plaintiff will likely prevail on the merits; rather, the plaintiff must only present factual allegations sufficient “to raise a right to relief above the speculative level.” Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555 (2007) (citing 5 C.

Wright & A. Miller, Federal Practice, and Procedure § 1216, pp. 235-236 (3d ed. 2004)); see also Ashcroft v. Iqbal, 556 U.S. 662 (2009). A complaint should only be dismissed pursuant to Rule 12(b)(6) if it fails to allege “enough facts to state a claim to relief that is plausible on its face.” Twombly, 550 U.S. at 570 (rejecting the traditional 12(b)(6) standard established in Conley vy. Gibson, 355 U.S. 41 (1957)). In making this determination, the court must accept as true all well- pled factual allegations in the complaint and views them in a light most favorable to the plaintiff. See U.S. Express Lines Ltd. v. Higgins, 281 F.3d 383, 388 (3d Cir. 2002). While a complaint does not need detailed factual allegations to survive a motion to dismiss, a complaint must provide more than labels and conclusions. See Twombly, 550 U.S. at 555. A “formulaic recitation of the elements of a cause of action will not do.” Jd. (citing Papasan v. Allain, 478 U.S. 265, 286 (1986)). Moreover, a court need not accept inferences drawn by a plaintiff if they are unsupported by the facts as set forth in the complaint. See California Pub. Emp. Ret. Sys. v. The Chubb Corp., 394 F.3d 126, 143 (3d Cir. 2004) (citing Morse v. Lower Merion Sch. Dist., 132 F.3d 902, 906 (3d Cir. 1997)). Nor must the Court accept legal conclusions disguised as factual allegations. See Twombly, 550 U.S. at 555. See also McTernan v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Conley v. Gibson
355 U.S. 41 (Supreme Court, 1957)
Papasan v. Allain
478 U.S. 265 (Supreme Court, 1986)
United States v. Bestfoods
524 U.S. 51 (Supreme Court, 1998)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Santiago v. Warminster Township
629 F.3d 121 (Third Circuit, 2010)
Burtch v. Milberg Factors, Inc.
662 F.3d 212 (Third Circuit, 2011)
Morse v. Lower Merion School District
132 F.3d 902 (Third Circuit, 1997)
U.S. Express Lines, Ltd. v. Higgins
281 F.3d 383 (Third Circuit, 2002)
McTernan v. City of York, Penn.
577 F.3d 521 (Third Circuit, 2009)
Griffin Plumbing & Heating Co. v. Jordan, Jones & Goulding, Inc.
463 S.E.2d 85 (Supreme Court of South Carolina, 1995)
Wicks v. Milzoco Builders, Inc.
470 A.2d 86 (Supreme Court of Pennsylvania, 1983)
Bilt-Rite Contractors, Inc. v. Architectural Studio
866 A.2d 270 (Supreme Court of Pennsylvania, 2005)
Forster v. Manchester
189 A.2d 147 (Supreme Court of Pennsylvania, 1963)
Althaus Ex Rel. Althaus v. Cohen
756 A.2d 1166 (Supreme Court of Pennsylvania, 2000)
Mitchell v. Moore
729 A.2d 1200 (Superior Court of Pennsylvania, 1999)

Cite This Page — Counsel Stack

Bluebook (online)
VALUE DRUG COMPANY v. ONLY ONE HUB, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/value-drug-company-v-only-one-hub-inc-pawd-2024.